President and
Principal Advisor
Robyn L. Phelps, MSc, PhD is a
Toxicologist and Safety
Pharmacologist with 25 years of scientific and drug development
experience. She has expertise in nonclinical pharmaceutical research and
development, and
has specialized skills in animal model
development, cardiovascular and pulmonary safety pharmacology.
Dr. Phelps has experience in all routes of
administration including dermal and inhalation. Her study experience
includes acute, subchronic and chronic toxicity, carcinogenicity and
reproductive toxicology in multiple species.
Dr. Phelps is an experienced manager
who can provide both high level and study specific oversight. She is
knowledgeable of domestic and international regulations and routinely interacts
with regulatory authorities. She has authored nonclinical documents
for national and international submissions as well as scientific manuscripts. Dr. Phelps serves as a
corporate scientific advisor and is a
member of the Roundtable of Toxicology Consultants.
For details, click the icon to view Dr.
Phelps's CV:
Principal
Advisor
Jan Bernal, BSc, DVM, is a
Veterinarian with 14 years of experience in veterinary medicine and surgery,
nonclinical research, and drug
development. Dr. Bernal has held positions in both clinical veterinary
practice and nonclinical contract research organizations. Her expertise
includes small animal, laboratory animal, and primate medicine as well as animal
colony management and regulatory adherence. She is a surgical expert skilled in
the development and utilization of unique models of drug administration and
monitoring technologies, and is an experienced study director. Dr. Bernal
served on the Board of Directors for the Academy of Surgical Research and has
published articles on telemetric monitoring and infusion device and delivery
models.
For details, click the icon to view Dr.
Bernal's CV:
Principal
Pathologist
Dan H. Lochner, DVM, MSc, Diplomate ACVP, is a Veterinary Pathologist with more than 22 years
experience in toxicologic pathology, drug safety and chemical toxicity. He
has held appointments in academics and in drug development both in the USA and
Switzerland, and is conversationally fluent in German. Dr. Lochner's range
of experience includes the pathologic/histopathologic assessment of acute,
subchronic and chronic toxicity, carcinogenicity and reproductive
toxicology studies in multiple species, including non-human primates. He
has experience in all routes of administration including dermal and ocular
application/implantation, and inhalation. Dr. Lochner is an experienced
author of toxicology/pathology reviews for national and international regulatory
submissions.
For details, click the icon to view Dr.
Lochner's CV:
Biomedical
Engineer
John R. Decker, BSE,
Electrical Engineering, Graduate Studies, Physiology, has extensive experience
in Inhalation Technology including instrument and software development, and
biologic testing. Mr. Decker is a well-recognized leader in the inhalation
field who has dedicated a 40 year career to understanding the biological effects
of environmental conditions on animals. His background includes generation
and monitoring of inhaled pharmaceuticals, radionuclides, vapors and gases,
smoke and chemical aerosols. He is an experienced program manager who has
developed, constructed, installed and validated numerous regulatory-compliant
automated systems for whole-body and nose-only inhalation exposure systems used
by the National Toxicology Program, government, chemical industry, and
pharmaceutical clients. In addition to the provision of program-specific
engineering and monitoring services, Mr. Decker is an excellent staff trainer.
For details, click the icon to view Mr.
Decker's CV:
